Viridian Therapeutics, Inc. (VRDN)
18.96
-0.44
(-2.27%)
USD |
NASDAQ |
Oct 05, 15:18
Viridian Therapeutics Price : 18.96 for Oct. 5, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 19.16 | 19.54 | 18.92 | 19.40 | 1.515M |
| Oct 01, 2026 | 20.61 | 20.61 | 18.99 | 18.99 | 3.375M |
| Sep 30, 2026 | 20.27 | 20.74 | 20.00 | 20.59 | 1.405M |
| Sep 29, 2026 | 20.68 | 20.85 | 19.73 | 20.00 | 1.234M |
| Sep 28, 2026 | 20.31 | 20.70 | 20.03 | 20.57 | 1.339M |
| Sep 25, 2026 | 20.75 | 21.00 | 20.16 | 20.47 | 2.091M |
| Sep 24, 2026 | 21.10 | 21.25 | 20.22 | 20.66 | 2.211M |
| Sep 23, 2026 | 22.11 | 22.18 | 21.20 | 21.43 | 2.858M |
| Sep 22, 2026 | 22.02 | 22.33 | 21.54 | 22.12 | 1.457M |
| Sep 21, 2026 | 22.28 | 22.40 | 21.53 | 21.58 | 1.746M |
| Sep 18, 2026 | 21.99 | 22.17 | 21.80 | 22.00 | 5.381M |
| Sep 17, 2026 | 22.88 | 22.97 | 21.72 | 21.93 | 1.268M |
| Sep 16, 2026 | 21.89 | 22.46 | 21.68 | 22.44 | 1.672M |
| Sep 15, 2026 | 21.98 | 22.14 | 21.40 | 21.83 | 1.211M |
| Sep 14, 2026 | 21.47 | 22.30 | 21.27 | 22.20 | 1.301M |
| Sep 11, 2026 | 22.48 | 22.70 | 21.18 | 21.24 | 944077.0 |
| Sep 10, 2026 | 22.40 | 22.60 | 21.99 | 22.29 | 1.310M |
| Sep 09, 2026 | 23.11 | 23.58 | 22.70 | 22.73 | 1.578M |
| Sep 08, 2026 | 22.38 | 23.84 | 22.22 | 23.17 | 1.829M |
| Sep 04, 2026 | 22.62 | 23.03 | 22.62 | 22.92 | 759916.0 |
| Sep 03, 2026 | 23.08 | 23.28 | 22.57 | 22.96 | 1.194M |
| Sep 02, 2026 | 23.11 | 23.74 | 22.39 | 22.78 | 1.417M |
| Sep 01, 2026 | 23.02 | 23.34 | 22.88 | 23.03 | 998383.0 |
| Aug 31, 2026 | 22.94 | 23.27 | 22.62 | 23.16 | 1.049M |
| Aug 28, 2026 | 23.58 | 23.70 | 23.04 | 23.08 | 778882.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ACADIA Pharmaceuticals, Inc. | 20.27 |
| Alnylam Pharmaceuticals, Inc. | 220.97 |
| Savara, Inc. | 4.82 |
| Vericel Corp. | 40.79 |
| Biogen, Inc. | 223.16 |
Price Related Metrics
| PS Ratio | 25.74 |
| Price to Book Value | 3.806 |
| Earnings Yield | -19.56% |
| Market Cap | 2.147B |